These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2480654

  • 1. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
    Corti A, Sarubbi E, Soffientini A, Nolli ML, Zanni A, Galimberti M, Parenti F, Cassani G.
    Thromb Haemost; 1989 Nov 24; 62(3):934-9. PubMed ID: 2480654
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
    Kurokawa T, Iwasa S, Kakinuma A, Stassen JM, Lijnen HR, Collen D.
    Thromb Haemost; 1991 Dec 02; 66(6):684-93. PubMed ID: 1796414
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L, Lijnen HR, Van Nuffelen A, Demarsin E, Collen D.
    Thromb Haemost; 1990 Aug 13; 64(1):53-60. PubMed ID: 2148847
    [Abstract] [Full Text] [Related]

  • 7. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.
    Kroon ME, Koolwijk P, van Goor H, Weidle UH, Collen A, van der Pluijm G, van Hinsbergh VW.
    Am J Pathol; 1999 Jun 13; 154(6):1731-42. PubMed ID: 10362798
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
    Corti A, Nolli ML, Soffientini A, Cassani G.
    Thromb Haemost; 1986 Oct 21; 56(2):219-24. PubMed ID: 3101222
    [Abstract] [Full Text] [Related]

  • 10. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT.
    Exp Cell Res; 1996 May 01; 224(2):344-53. PubMed ID: 8612711
    [Abstract] [Full Text] [Related]

  • 11. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK.
    Cancer Res; 1996 Jun 15; 56(12):2837-43. PubMed ID: 8665523
    [Abstract] [Full Text] [Related]

  • 12. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F, Van Hoef B, Bini A, Collen D, Lijnen HR.
    Biochemistry; 1998 May 19; 37(20):7231-6. PubMed ID: 9585535
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 19; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 15. Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue.
    Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H, Graeff H, Müller M, Schmitt M.
    Am J Pathol; 1997 Apr 19; 150(4):1231-44. PubMed ID: 9094980
    [Abstract] [Full Text] [Related]

  • 16. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.
    Schmitt M, Chucholowski N, Busch E, Hellmann D, Wagner B, Goretzki L, Jänicke F, Günzler WA, Graeff H.
    Semin Thromb Hemost; 1991 Jul 19; 17(3):291-302. PubMed ID: 1724574
    [Abstract] [Full Text] [Related]

  • 17. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E, Fibbi G, Pucci M, Caldini R, Chevanne M, Del Rosso M.
    Exp Cell Res; 1994 Aug 19; 213(2):438-48. PubMed ID: 8050501
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
    De Petro G, Copeta A, Barlati S.
    Exp Cell Res; 1994 Jul 19; 213(1):286-94. PubMed ID: 8020601
    [Abstract] [Full Text] [Related]

  • 20. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J, Jögi A, Lund IK, Rønø B, Rasch MG, Gårdsvoll H, Lund LR, Ploug M, Rømer J, Danø K, Høyer-Hansen G.
    Thromb Haemost; 2007 Jun 19; 97(6):1013-22. PubMed ID: 17549305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.